Table 3 Diagnostic tests for metabolic response criteria based on MTV and SUVmean
From: Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
Value (%) | 95% CI (%) | |
|---|---|---|
MTV - Locoregional recurrence | ||
Pretest probability | 23.8 | 5.5 – 42.0 |
Sensitivity | 60.0 | 17.1 – 102.9 |
Specificity | 93.8 | 81.9 – 105.6 |
Diagnostic Accuracy | 85.7 | 70.8 – 100.7 |
Positive Predictive Value | 75.0 | 32.6 – 117.4 |
Negative Predictive Value | 88.2 | 72.9 – 103.6 |
SUVmean - Distant metastasis | ||
Pretest probability | 42.9 | 21.7 – 64.0 |
Sensitivity | 66.7 | 35.9 – 97.5 |
Specificity | 83.3 | 62.3 – 104.4 |
Diagnostic Accuracy | 76.2 | 58.0 – 94.4 |
Positive Predictive Value | 75.0 | 45.0 – 105.0 |
Negative Predictive Value | 76.9 | 54.0 – 99.8 |